Arcadia Biosciences, Inc. (RKDA) Financials

$4.90

north_east
$0.05 (1.03%)
Day's range
$4.71
Day's range
$4.93

RKDA Income statement / Annual

Last year (2023), Arcadia Biosciences, Inc.'s total revenue was $5.33 M, a decrease of 46.46% from the previous year. In 2023, Arcadia Biosciences, Inc.'s net income was -$13.98 M. See Arcadia Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $5.33 M $9.96 M $6.78 M $8.03 M $1.17 M $1.46 M $4.03 M $3.19 M $5.41 M $6.98 M
Cost of Revenue $3.30 M $9.80 M $8.71 M $5.20 M $885,000.00 $661,000.00 $283,000.00 $895,000.00 $892,000.00 $2.00 M
Gross Profit $2.03 M $154,000.00 -$1.93 M $2.84 M $284,000.00 $803,000.00 $3.74 M $2.29 M $4.52 M $4.99 M
Gross Profit Ratio 0.38 0.02 -0.28 0.35 0.24 0.55 0.93 0.72 0.84 0.71
Research and Development Expenses $1.39 M $1.51 M $3.89 M $7.96 M $7.10 M $6.07 M $7.41 M $8.66 M $8.97 M $10.01 M
General & Administrative Expenses $0.00 $0.00 $0.00 $16.47 M $13.57 M $11.60 M $10.65 M $12.25 M $11.12 M $10.13 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $14.51 M $18.05 M $22.94 M $16.47 M $13.57 M $11.60 M $10.65 M $12.25 M $11.12 M $10.13 M
Other Expenses $73,000.00 $33,000.00 $10.11 M $105,000.00 $466,000.00 -$3.61 M $281,000.00 $340,000.00 $521,000.00 $0.00
Operating Expenses $15.90 M $19.56 M $26.83 M $24.43 M $20.67 M $17.67 M $18.06 M $20.91 M $20.09 M $20.14 M
Cost And Expenses $19.27 M $29.36 M $35.54 M $29.63 M $21.55 M $18.33 M $18.34 M $21.81 M $20.98 M $22.14 M
Interest Income $695,000.00 $289,000.00 $20,000.00 $47,000.00 $5,000.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $289,000.00 $20,000.00 $47,000.00 $5,000.00 $0.00 $747,000.00 $1.32 M $2.66 M $1.39 M
Depreciation & Amortization $287,000.00 $1.36 M $1.04 M $662,000.00 $194,000.00 $154,000.00 $279,000.00 $304,000.00 $294,000.00 $358,000.00
EBITDA -$13.58 M -$13.65 M -$23.27 M -$5.44 M -$28.67 M -$13.32 M -$14.66 M -$17.98 M -$14.98 M -$15.39 M
EBITDA Ratio -2.55 -2.28 -2.71 -2.59 -17.48 -15.63 -3.42 -5.64 -2.72 -2.12
Operating Income Ratio -2.62 -1.95 -5.24 -2.69 -17.43 -11.52 -3.56 -5.84 -2.87 -2.17
Total Other Income/Expenses Net $781,000.00 $3.19 M $19.39 M $6.63 M -$9.49 M $3.40 M -$1.37 M -$979,000.00 -$2.37 M -$1.99 M
Income Before Tax -$13.16 M -$15.60 M -$16.13 M -$6.15 M -$28.87 M -$13.47 M -$15.68 M -$19.60 M -$17.93 M -$17.14 M
Income Before Tax Ratio -2.47 -1.57 -2.38 -0.77 -24.7 -9.2 -3.89 -6.15 -3.31 -2.46
Income Tax Expense $8,000.00 $14,000.00 $2,000.00 -$124,000.00 $2,000.00 $10,000.00 $26,000.00 $25,000.00 $26,000.00 $263,000.00
Net Income -$13.98 M -$15.61 M -$16.13 M -$6.03 M -$28.87 M -$13.48 M -$15.71 M -$19.62 M -$17.96 M -$18.34 M
Net Income Ratio -2.62 -1.57 -2.38 -0.75 -24.7 -9.21 -3.9 -6.16 -3.32 -2.63
EPS -11.3 -26.05 -30.33 -24.2 -181.5 -143.16 -291.38 -353.85 -503 -448.39
EPS Diluted -11.3 -26.05 -30.33 -24.2 -181.5 -143.16 -291.38 -353.85 -503 -448.39
Weighted Average Shares Out $1.24 M $599,389.00 $532,015.00 $248,975.00 $159,077.00 $94,160.00 $53,905.00 $55,458.00 $35,698.00 $40,900.00
Weighted Average Shares Out Diluted $1.24 M $599,389.00 $532,015.00 $248,975.00 $159,077.00 $94,160.00 $53,905.00 $55,458.00 $35,698.00 $40,900.00
Link